Evidence map›Paper›PMID 36517606›Full record

ArticleEuropean radiology2023

Temporary inferior vena cava filters factors associated with non-removal.

Sabrina Dehbi, Rémi Grange, Geraldine Poenou, Elie Ayoub, Claire Boutet, Fabrice-Guy Barral, Laurent Bertoletti, Sylvain Grange

Abstract read
PubMed Publisher
In one paragraph

Article in European radiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 13 citations in OpenAlex.

  1. Optimizing the management strategy for inferior vena cava filter.Quantitative imaging in medicine and surgery · 2025
    Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Sabrina DehbiCHU de St-Etienne, Service de Radiologie, Hôpital Nord, CHU de St-Etienne, Avenue Albert Raimond, Saint-Etienne, France.
Rémi GrangeCHU de St-Etienne, Service de Radiologie, Hôpital Nord, CHU de St-Etienne, Avenue Albert Raimond, Saint-Etienne, France.
Geraldine PoenouCHU de St-Etienne, Service de Médecine Vasculaire et Thérapeutique, Hôpital Nord, CHU de St-Etienne, Saint-Etienne, Avenue Albert Raimond, Saint-Etienne, France.
Elie AyoubCHU de St-Etienne, Service de Médecine Vasculaire et Thérapeutique, Hôpital Nord, CHU de St-Etienne, Saint-Etienne, Avenue Albert Raimond, Saint-Etienne, France.
Claire BoutetCHU de St-Etienne, Service de Radiologie, Hôpital Nord, CHU de St-Etienne, Avenue Albert Raimond, Saint-Etienne, France.
Fabrice-Guy BarralCHU de St-Etienne, Service de Radiologie, Hôpital Nord, CHU de St-Etienne, Avenue Albert Raimond, Saint-Etienne, France.
Laurent BertolettiCHU de St-Etienne, Service de Médecine Vasculaire et Thérapeutique, Hôpital Nord, CHU de St-Etienne, Saint-Etienne, Avenue Albert Raimond, Saint-Etienne, France.
Sylvain GrangeCHU de St-Etienne, Service de Radiologie, Hôpital Nord, CHU de St-Etienne, Avenue Albert Raimond, Saint-Etienne, France. sylvain.grange@chu-st-etienne.fr.ORCID http://orcid.org/0000-0003-3706-297X
Hôpital Nord · FRInserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesInferior vena cava filter (IVCF) placement is indicated when there is a deep vein thrombosis and/or a pulmonary embolism and a contraindication of anticoagulation. Due to the increased risk of recurrent deep venous thrombosis when left in place, IVCF removal is indicated once anticoagulant treatment can be reintroduced. However, many temporary IVCF are not removed. We aimed to analyze the removal rate and predictors of filter non-removal in a university hospital setting.

methodsWe collected all the data of consecutive patients who had a retrievable IVCF inserted at the Saint-Etienne University Hospital (France) between April 2012 and November 2019. Rates of filter removal were calculated. We analyzed patient characteristics to assess factors associated with filter non-removal, particularly in patients without a definitive filter indication. The exclusion of this last category of patients allowed us to calculate an adjusted removal rate.

resultsThe overall removal rate of IVCF was 40.5% (IC 95% 35.6-45.6), and the adjusted removal rate was 62.9 % (IC 95% 56.6-69.2%). No major complications were noted. Advanced age (p < 0.0001) and cancer presence (p < 0.003) were statistically significant predictors of patients not being requested to make a removal attempt.

conclusionsAlthough most of the filters placed are for therapeutic indications validated by scientific societies, the removal rate in this setting remains suboptimal. The major factors influencing IVCF removal rate are advanced age and cancer presence. KEY POINTS: • Most vena cava filters are placed for therapeutic indications validated by scientific societies. • Vena cava filter removal rates in this setting remain suboptimal. • Major factors influencing IVCF removal rate are advanced age and cancer presence.

Indexed as

NeoplasmsPulmonary EmbolismVena Cava FiltersVenous ThrombosisDevice RemovalHumansRetrospective StudiesTreatment OutcomeVena Cava, InferiorNeoplasmsPulmonary embolismVena cava filtersVenous thrombosis

Identifiers

PMID36517606
OpenAlexW4311484862

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.